Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients

View ORCID ProfileShinya Tsuzuki, Yusuke Miyazato, Mari Terada, Shinichiro Morioka, Norio Ohmagari, Philippe Beutels
doi: https://doi.org/10.1101/2021.09.27.21264225
Shinya Tsuzuki
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
2Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shinya Tsuzuki
  • For correspondence: stsuzuki@hosp.ncgm.go.jp
Yusuke Miyazato
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mari Terada
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinichiro Morioka
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norio Ohmagari
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Beutels
2Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The empirical basis for a quantitative assessment of the disease burden imposed by long-COVID is currently scant. We aimed to assess the disease burden caused by long-COVID in Japan.

Methods We conducted a cross sectional self-report questionnaire survey. The questionnaire was mailed to 530 eligible patients, who were recovered from acute COVID-19 in April 2021. Answers were classified into two groups; participants who have no symptom and those who have any ongoing symptoms that lasted longer than four weeks at the time of the survey. We compared health-related quality of life scores estimated by the EQ-5D-3L questionnaire between these two groups after adjusting basic characteristics of the participants by propensity score matching.

Results 349 participants reported no symptoms and 108 reported any symptoms at the time of the survey. The participants who reported any symptoms showed a lower value on a Visual Analogue Scale (median 70 [IQR 60-80]) and on the EQ-5D-3L (median 0.81 [IQR 0.77-1.0]) than those reporting no symptoms (median 85 [IQR 75-90] and 1.0 [IQR 1.0-1.0], respectively). After adjusting for background characteristics, these trends did not change substantially (Visual Analog Scale: median 70 [IQR 60-80] vs 80 [IQR 77-90], EQ-5D-3L: median 0.81 [IQR 0.76-1.0] vs 1.0 [IQR 1.0-1.0]).

Conclusions Due to their long duration, long-COVID symptoms represent a substantial disease burden expressed in impact on health-related quality of life.

Trial registration Not applicable.

Competing Interest Statement

PB reports grants from the EU's SC1-PHE-CORONAVIRUS-2020 programme, Pfizer, GlaxoSmithKlein, and European Commission IMI, unrelated to this work.

Funding Statement

This research was funded by JSPS KAKENHI [Grant number 18K17369], a grant for the National Center for Global Health and Medicine [20A05], AMED under Grant Number JP20fk0108502 and the Health and Labour Sciences Research Grant, Research for risk assessment and implementation of crisis management functions for emerging and re233 emerging infectious diseases.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was reviewed and approved by the Ethics Committee of the Center Hospital of the NCGM (NCGM-G-004121-00)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available upon request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 29, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
Shinya Tsuzuki, Yusuke Miyazato, Mari Terada, Shinichiro Morioka, Norio Ohmagari, Philippe Beutels
medRxiv 2021.09.27.21264225; doi: https://doi.org/10.1101/2021.09.27.21264225
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
Shinya Tsuzuki, Yusuke Miyazato, Mari Terada, Shinichiro Morioka, Norio Ohmagari, Philippe Beutels
medRxiv 2021.09.27.21264225; doi: https://doi.org/10.1101/2021.09.27.21264225

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)